NEW YORK, April 24-AnVil and Genomics Collaborative will be working together on a pilot project to apply new data analysis and visualization systems to microarray data, AnVil said in a statement today.

In the project, AnVil will apply its visualization and analysis tools to GCI's DNA microarray data.

The partnership is designed to help GCI identify gene expression patterns that could suggest new drug targets for inflammatory disease, especially rheumatoid arthritis.

AnVil, based in Burlington, Mass., is a privately held bioinformatics company.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.